Pancreatic cancer is among the deadliest forms of cancer, with most patients diagnosed after the disease has already spread ...

In this study, researchers evaluated the dose-response relationship between body mass index and the risk of developing pancreatic cancer by the age of 50 years.

Innova Therapeutics, a biopharmaceutical company, has announced that it has completed the acquisition of Enci Therapeutics. The acquisition includes Enci Therapeutics' main cancer therapeutic program, ...

Cancer biology is a multidisciplinary field that continues to confront formidable challenges, with cancer ranking as a principal cause of global morbidity ...